Safe pharmaceutical manufacturing relies on controlled conditions. From validated processes and cleanroom discipline to batch records, quality systems and regulatory oversight, the industry depends on the belief that critical systems will behave as expected.
If they do not, product quality, operational continuity and patient safety are at stake.
That confidence is being tested by the way modern pharma facilities have evolved. Pharma 5.0 brings automation, AI, advanced analytics, connected assets and more adaptive production models into the heart of manufacturing.
These technologies can improve efficiency, predict failures and support better decisions, but they also increase our dependence on the integrity of the systems beneath them.
A plant cannot be truly intelligent if the data, logic and safety functions it relies on cannot be trusted, states Denrich Sananda (pictured), Managing Partner and Senior Consultant at Arista Cyber.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.
Subscribe now Already a subscriber? Sign in here.